Search clinical trials for: DAIDS, FTIH, HIV-1, MAD, SAD

Total 57164 results

University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women

HIV-1-infection | Antenatal Care

Malawi
University of Connecticut
National Institute of Mental Health (NIMH)

Completed

HIV Internet Sex Study: Internet-based STI/HIV Prevention for HIV+ Internet Users (HINTS)

Risk Reduction | HIV-1 Infection
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

HIV

United States, France, Argentina, Chile, Mexico, Costa Rica, Panama, Brazil, Puerto Rico, Thailand
International Partnership for Microbicides, Inc.

Completed

A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels

HIV Infections

Belgium
Johns Hopkins University
Genentech, Inc.; FDA Office of Orphan Products Development

Completed

Clinical Trial on Treatment of Intraventricular Hemorrhage (CLEAR IVH)

Intraventricular Hemorrhage

United States, Germany, Canada, United Kingdom
Helios Salud
ViiV Healthcare

Unknown

Epidemiological and Clinical Description of Women Living With HIV in Selected Countries of Latin America

Hiv | HIV-1-infection

Argentina
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Sitagliptin for Reducing Inflammation and Immune Activation

HIV-1 Infection

United States
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Terminated

Probiotic Visbiome for Inflammation and Translocation in HIV Ι (PROOV IT I)

HIV-1 Infection

Canada
Holdsworth House Medical Practice

Completed

Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months (CVD)

Cardiovascular Disease | HIV-1 Infection

Australia
University of North Carolina, Chapel Hill
Medical University of South Carolina; National Institute of Mental Health (NIMH) and other collaborators

Completed

AllyQuest Adherence App Intervention for HIV-positive Men Who Have Sex With Men and Transgender Women: Pilot Trial (AQ2)

HIV/AIDS | Medication Adherence | Hiv | Sexual Behavior | Sexually Transmitted Infections (Not HIV or Hepatitis)

United States
International Partnership for Microbicides, Inc.

Completed

A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium

HIV Infections

Belgium
GCS IHFB Cognacq-Jay
Hospital Ambroise Paré Paris

Completed

HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy

HIV-1-infection | HIV Associated Neurocognitive Disorder

France
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

HIV
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate

HIV-1 Infection

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

HIV-1 Infection

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Biocine

Completed

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

HIV Infections

United States
University Hospital, Bordeaux

Completed

SkIn, Muscle and Bone Aging Determinants in HIV Infected-patients. (SIMBAD)

HIV-1-infection | Marker; Structural
Weill Medical College of Cornell University
AdhereTech

Completed

HIV Adherence Bottle Intervention Trial (HABIT)

Adherence, Medication | HIV-1-infection
Montefiore Medical Center
Centers for Disease Control and Prevention

Completed

Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV

HIV-1-infection | Pre-exposure Prophylaxis

United States
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Unknown

Probiotic Visbiome for Inflammation and Translocation in HIV II (PROOV IT II)

HIV-1 Infection

Canada
Objectif Recherche Vaccins SIDA
Fondation Bettencourt-Schueller

Completed

Towards HIV Functional Cure (ULTRASTOP)

Chronic HIV-1 Infection

France
Fundacion Clinic per a la Recerca Biomédica

Unknown

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

HIV-1-infection | Solid Organ Transplant

Spain
Gilead Sciences

Completed

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

HIV Infections

United States
Thomas Jefferson University

Completed

Safety Study of Elvucitabine in HIV-1 Subjects

HIV Infections

United States
Gilead Sciences

Completed

Combination of Efavirenz and Truvada - COMET Study

HIV Infections
Avioq, Inc.
Duke Clinical Research Institute; University of North Carolina; Clinical Reference...

Completed

VioOne HIV Profile Supplemental Assay

HIV Infections

United States
University of California, San Francisco
Johns Hopkins University

Completed

Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals

HIV-1 Infection

United States
Kenya Medical Research Institute
Merck Sharp & Dohme LLC; University of Washington

Completed

A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years

HIV-1 Infection | Human Papillomavirus
Alexion
Achillion, a wholly owned subsidiary of Alexion

Completed

Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

HIV Infections

United States, Puerto Rico
Bayside Health

Unknown

The Role of Naive T-Cells in HIV Pathogenesis

HIV Infections

Australia
Institut de Recherche pour le Developpement
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers (PHPT-5)

HIV Infections

Thailand
National Institute of Allergy and Infectious Diseases...

Completed

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

HIV Infections | HIV Seronegativity

Brazil, Peru, Haiti, Trinidad and Tobago
Johns Hopkins Bloomberg School of Public Health
University of California, San Francisco; University of Toronto; National Institute... and other collaborators

Completed

HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)

HIV-1 Virologic Response

South Africa
State University of New York at Buffalo
Gilead Sciences

Active, not recruiting

Bictegravir in the Elderly Living With HIV (BICEP)

HIV-1-infection

United States
Allegheny Singer Research Institute (also known...

Active, not recruiting

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA (CAPRI)

HIV Infections | HIV-1-infection | HIV I Infection

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Safety and Immunogenicity of HIV-1 Vaccines C62-M4 or C1C62-M3m4 in Persons With HIV-1 Suppressed on ART (CM HIV-Core008)

HIV-1-infection | HIV Vaccine

United States
CytoDyn, Inc.

Completed

Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection

HIV Infections | HIV -1 Infection

United States
Merck Sharp & Dohme LLC

Completed

Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)

HIV-1 | Central Nervous System
University of California, Los Angeles
University of California, San Francisco

Completed

Contingency Management for PrEP Adherence and/or Methamphetamine Use (C-MAX)

Methamphetamine-dependence | HIV-1-infection

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)

HIV Infections | HIV-1 Infection
Sociedad Andaluza de Enfermedades Infecciosas
Consejeria de Salud. Junta de Andalucia. Spain

Completed

Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage

HIV Infection | HIV-1 Infection

Spain
Institut de Recherche pour le Developpement
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand

HIV Infections | Pregnancy

Thailand
Institut de Recherche pour le Developpement
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Terminated

Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand (PHPT-5)

HIV Infections | Pregnancy

Thailand
Unity Health Toronto
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

Near Patient Study of the OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test in Oral Fluid and Fingerstick Whole Blood

HIV Infections | HIV Testing

Canada
International Partnership for Microbicides, Inc.

Completed

Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials

HIV Infections

South Africa, Rwanda
International Partnership for Microbicides, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women (ASPIRE)

HIV Infections

Malawi, South Africa, Uganda, Zimbabwe
International Partnership for Microbicides, Inc.

Completed

Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women

HIV Infections

South Africa, Uganda
International Partnership for Microbicides, Inc.

Completed

Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

HIV Infections

United States
International Partnership for Microbicides, Inc.

Withdrawn

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

HIV Infections

South Africa, Malawi, Rwanda, Zimbabwe
Erasmus Medical Center

Recruiting

Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV (EX VIVO)

HIV Infections | HIV-1-infection | HIV-2 Infection

Netherlands

Search clinical trials for: DAIDS, FTIH, HIV-1, MAD, SAD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations